Dr. Iwamoto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Independence Way
Princeton, NJ 08540Phone+1 609-720-5379Fax+1 908-504-7348
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1997 - 2001
NYU Grossman School of MedicineResidency, Internal Medicine, 1995 - 1997
Emory University School of MedicineClass of 1995
Certifications & Licensure
NJ State Medical License 2002 - 2025
Publications & Presentations
PubMed
- 4 citationsNo Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist The...Hwa-Ping Feng, Zifang Guo, Luzelena Caro, William L. Marshall, Fang Liu
Clinical and Translational Science. 2018-07-24 - 129 citationsEffect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of RaltegravirLarissa Wenning, William D. Hanley, Diana M. Brainard, Amelia S. Petry, Kalyan Ghosh
Antimicrobial Agents and Chemotherapy. 2009-07-01 - 41 citationsUGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study.Wang Yh, Michele Trucksis, Joshua McElwee, Peggy H. Wong, Maciolek C
Clinical Pharmacology and Therapeutics. 2012-07-01
Journal Articles
- Clinical Evaluation of MK‐2640: An Insulin Analog with Glucose‐Responsive PropertiesMarian Iwamoto, MD, Clinical Pharmacology & Therapeutics
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
